BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33542720)

  • 1. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells.
    Zhang P; Nguyen J; Abdulla F; Nelson AT; Beckman JD; Vercellotti GM; Belcher JD
    Front Immunol; 2021; 12():632709. PubMed ID: 33841413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Young M; Chen C; Nguyen J; Burhop K; Tran P; Vercellotti GM
    Blood; 2013 Oct; 122(15):2757-64. PubMed ID: 23908468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Mahaseth H; Welch TE; Otterbein LE; Hebbel RP; Vercellotti GM
    J Clin Invest; 2006 Mar; 116(3):808-16. PubMed ID: 16485041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
    Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
    Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
    An R; Man Y; Cheng K; Zhang T; Chen C; Wang F; Abdulla F; Kucukal E; Wulftange WJ; Goreke U; Bode A; Nayak LV; Vercellotti GM; Belcher JD; Little JA; Gurkan UA
    Br J Haematol; 2023 May; 201(3):552-563. PubMed ID: 36604837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
    Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
    Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease.
    Allali S; Rignault-Bricard R; de Montalembert M; Taylor M; Bouceba T; Hermine O; Maciel TT
    Blood; 2022 Nov; 140(18):1972-1982. PubMed ID: 35984906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Causes Pain in Sickle Mice
    Lei J; Paul J; Wang Y; Gupta M; Vang D; Thompson S; Jha R; Nguyen J; Valverde Y; Lamarre Y; Jones MK; Gupta K
    Antioxid Redox Signal; 2021 Feb; 34(4):279-293. PubMed ID: 32729340
    [No Abstract]   [Full Text] [Related]  

  • 17. The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease.
    Belcher JD; Nataraja S; Abdulla F; Zhang P; Chen C; Nguyen J; Ruan C; Singh M; Demes S; Olson L; Stickens D; Stanwix J; Clarke E; Huang Y; Biddle M; Vercellotti GM
    Front Med (Lausanne); 2023; 10():1101501. PubMed ID: 37144034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes.
    Sultana C; Shen Y; Rattan V; Johnson C; Kalra VK
    Blood; 1998 Nov; 92(10):3924-35. PubMed ID: 9808586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
    Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
    Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM
    Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.